We can freeze our wrinkles, smooth our fine lines and zap away our skin imperfections. But the biggest cosmetic complaint of many - the double chin - has been neglected in the world of noninvasive cosmetic surgery advances. The traditional way to treat a double chin has been with a full-on face lift. But that may be about change.

An injection called ATX-101, which targets double chins, is nearing approval by the U.S. Food and Drug Administration (FDA). On Monday the drug was backed by an independent panel to the FDA, which brings it one step closer to full approval. ATX-101 consists of deoxycholic acid that's injected into skin to target and eliminate fat cells under the chin without spreading to surrounding tissue. Its maker, Kythera Biopharmaceuticals Inc., hopes to make the injections available in the back half of 2015. To read more about this procedure, click on the link below.

Belotero (Merz) has become the treatment of choice and standard of care for the cosmetic treatment of fine, etched-in facial lines, according to a dermatologist Cosmetic Surgery Times interviewed on the topic in 2012.

IDerek H. Jones, M.D., clinical associate professor of dermatology, University of California, Los Angeles, and founder and director, Skin Care and Laser Physicians of Beverly Hills, says he uses the highly cross-linked hyaluronic acid filler to treat vertical, etched-in perioral and fine, superficial etched-in radial cheek lines. But there is a caveat: Belotero requires injection know-how. "It does take some experience because it is injected differently [than other hyaluronic acid fillers]," he says.

To read more about Dr. Jones' tips and techniques regarding Belotero, click on the link below.

This month we are offering a $50 credit to models who register for our training seminar being held in Richmond, VA on April 18, 2015.

Register by clicking on the link above and enter NEWSLETTER in the notes section, or give us a call at (512) 301-2125.